Bisdemethoxycurcumin
Bisdemethoxycurcumin is an orally effective curcuminoid. Bisdemethoxycurcumin downregulates pro-inflammatory cytokines in macrophages by inhibiting the phosphorylation of PI3K/Akt and p38 MAPK. Bisdemethoxycurcumin relieves autophagy inhibition and promotes lipophagy to clear vascular smooth muscle foam cells by inhibiting the PDK1/Akt/mTOR pathway. Bisdemethoxycurcumin activates the cAMP/Epac/AMPKα axis and the NRF2/HO-1 antioxidant axis, thereby indirectly inhibiting the phosphorylation of NF-κB p65 and pro-inflammatory outputs such as IL-1β/IL-6/TNF-α, so as to alleviate pulmonary oxidative stress, inflammatory infiltration and pulmonary edema. Bisdemethoxycurcumin blocks NLRP3-mediated pyroptosis and protects cartilage extracellular matrix degradation by activating NRF2/HO-1. Bisdemethoxycurcumin also exerts a synergistic effect with potassium iodide against Candida.
For research use only. We do not sell to patients.
- CAS No.: 52328-96-8
- Formula: C19H16O4
- Molecular Weight:308.33
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
All AMPK Isoforms
More
Biological Activity
Description
In Vitro
Bisdemethoxycurcumin stably binds to purified human SRC, EGFR, AKT1, and PIK3R1 proteins, with the strongest binding affinity to AKT1 (-9.2 kcal/mol)[1].
Bisdemethoxycurcumin (1-256 μM; 24-48 h) exhibits no cytotoxicity against ATDC5 chondrocytes at concentrations ≤ 8 μM within 24 h or 48 h, with a 48 h CC50 value of 14.62 μM[2].
Bisdemethoxycurcumin (2-8 μM; 7 days) dose-dependently reverses TBHP-induced reduction in the area of ATDC5 chondrocytes after 7 days of high-density culture[2].
Bisdemethoxycurcumin (2.5-40 μM; 48 h) shows no cytotoxicity against RAW264.7 cells at concentrations of 2.5 μM and 5 μM after 48 h of incubation, but induces significant cytotoxicity at concentrations ≥ 10 μM[1].
Bisdemethoxycurcumin (2.5 μM; 25 h) inhibits LPS-induced phosphorylation of Akt, PI3K and p38 proteins in RAW264.7 cells, but has no effect on the phosphorylation of ERK1/2 or JNK[1].
Bisdemethoxycurcumin exhibits favorable pharmacokinetic properties and targets the PI3K/AKT signaling pathway, in which PDK1 serves as a key potential mediator of its anti-atherosclerotic effects[3].
Bisdemethoxycurcumin (2.5 μM; 25 h) reduces the mRNA expression levels of IL-6, IL-1β, TNF-α and MCP-1 in LPS (HY-D1056)-induced RAW264.7 cells[1].
Bisdemethoxycurcumin (2-8 μM; 48 h) reverses TBHP-induced extracellular matrix (ECM) degradation in ATDC5 chondrocytes in a dose-dependent manner by upregulating type II collagen and aggrecan, and downregulating ADAMTS4 and MMP3[2].
Bisdemethoxycurcumin (2-8 μM; 48 h) activates the Nrf2/HO-1 pathway in a dose-dependent manner, and inhibits pyroptosis in TBHP-stimulated ATDC5 chondrocytes by upregulating Nrf2 and HO-1, and downregulating NLRP3, GSDMD, Caspase 1 and IL-1β, with a treatment duration of 48 h[2].
Bisdemethoxycurcumin (8 μM; 24 h) significantly reduces the TBHP-induced upregulation of ADAMTS5 and NLRP3 protein expressions in ATDC5 chondrocytes[2].
Bisdemethoxycurcumin (10-40 μM; 12 h) reduces lipid accumulation in mouse aortic vascular smooth muscle cells stimulated by oxidized low-density lipoprotein (ox-LDL) (HY-NP013) and promotes cholesterol efflux[3].
Bisdemethoxycurcumin (20 μM; 12 h) promotes autophagy and reduces lipid deposition in ox-LDL-stimulated mouse aortic vascular smooth muscle cells by inhibiting the PDK1/Akt/mTOR signaling pathway[3].
The autophagy-promoting and lipid-lowering effects of Bisdemethoxycurcumin (20 μM; 12 h) in ox-LDL-stimulated mouse aortic vascular smooth muscle cells depend on the downregulation of PDK1[3].
Bisdemethoxycurcumin (10 µmol; 18 h) inhibits LPS-induced inflammatory responses and oxidative stress in primary mouse peritoneal macrophages by suppressing NF-κB p65 activation and restoring the levels of redox balance markers[4].
Bisdemethoxycurcumin (10 µmol; 18 h) protects primary mouse peritoneal macrophages against LPS-induced inflammation and oxidative stress by activating AMPKα[4].
Combination treatment with bisdemethoxycurcumin (40 μM) and potassium iodide achieves a maximum reduction of 3.5 log10 CFU/mL in Candida albicans ATCC 10231 biofilms at 1 hour post-irradiation[6].
When Bisdemethoxycurcumin (20-80 μM) is used alone, the amount of hydroxyl radicals it generates shows a strong correlation with the reduction degree of Candida albicans ATCC 10231 biofilms; however, when it is used in combination with potassium iodide, the correlation is only moderate after irradiation[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RAW264.7 murine macrophage cells
-
Concentration:2.5, 5, 10, 20, and 40 μM
-
Incubation Time:48 h
-
Result:Showed no cytotoxicity at 2.5 μM and 5 μM, with cell viability comparable to vehicle control.
Reduced cell viability to ~80% at 10 μM.
Reduced cell viability to ~70% at 20 μM.
Reduced cell viability to ~30% at 40 μM.
-
Cell Line:LPS-stimulated RAW264.7 murine macrophage cells
-
Concentration:2.5 μM
-
Incubation Time:1 h pre-incubation, followed by 24 h LPS co-incubation
-
Result:Significantly reduced LPS-induced elevation of IL-6 mRNA levels.
Significantly reduced LPS-induced elevation of IL-1β mRNA levels.
Significantly reduced LPS-induced elevation of TNF-α mRNA levels.
Significantly reduced LPS-induced elevation of MCP-1 mRNA levels.
-
Cell Line:LPS-stimulated RAW264.7 murine macrophage cells
-
Concentration:2.5 μM
-
Incubation Time:1 h pre-incubation, followed by 24 h LPS co-incubation
-
Result:Significantly reduced LPS-induced phosphorylation of Akt protein.
Significantly reduced LPS-induced phosphorylation of PI3K protein.
Significantly reduced LPS-induced phosphorylation of p38 protein.
Showed no significant effect on LPS-induced phosphorylation of ERK1/2 or JNK proteins.
-
Cell Line:ATDC5 chondrocyte cell line
-
Concentration:1, 2, 4, 8, 16, 32, 64, 128 and 256 μM
-
Incubation Time:24 h; 48 h
-
Result:Showed no cytotoxicity at concentrations up to 8 μM after 24 and 48 h.
Significantly reduced cell viability at concentrations ≥16 μM after 24 h.
Significantly reduced cell viability at concentrations ≥16 μM after 48 h.
Exhibited a CC50 value of 14.62 μM in ATDC5 cells after 48 h.
-
Cell Line:TBHP-stimulated ATDC5 chondrocyte cell line
-
Concentration:2, 4, and 8 μM (in combination with 20 ng/mL TBHP)
-
Incubation Time:48 h
-
Result:Dose-dependently upregulated Collagen II and aggrecan protein expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Dose-dependently downregulated ADAMTS4 and MMP3 protein expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Produced significant changes in protein expression at all tested concentrations compared to TBHP-only treatment.\nDose-dependently upregulated Nrf2 and HO-1 protein expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Dose-dependently downregulated NLRP3, GSDMD, Caspase 1, and IL-1β protein expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Produced significant changes in protein expression at all tested concentrations compared to TBHP-only treatment.
-
Cell Line:TBHP-stimulated ATDC5 chondrocyte cell line
-
Concentration:2, 4, and 8 μM (in combination with 20 ng/mL TBHP)
-
Incubation Time:48 h
-
Result:Dose-dependently upregulated Collagen II and aggrecan mRNA expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Dose-dependently downregulated ADAMTS4, ADAMTS5, MMP3, and MMP9 mRNA expression at 2, 4, and 8 μM compared to TBHP-only treatment.
Produced significant changes in mRNA expression at all tested concentrations compared to TBHP-only treatment.
-
Cell Line:TBHP-stimulated ATDC5 chondrocyte cell line
-
Concentration:8 μM (in combination with 20 ng/mL TBHP)
-
Incubation Time:24 h
-
Result:Significantly reduced ADAMTS5 positive staining area compared to TBHP-only treatment.
Significantly reduced NLRP3 positive staining area compared to TBHP-only treatment.
-
Cell Line:ox-LDL-stimulated mouse aortic vascular smooth muscle cells (VSMCs)
-
Concentration:20 μM
-
Incubation Time:12 h (pretreated)
-
Result:Increased the LC3B-II/LC3B-I ratio, Beclin-1, and ABCA1 protein levels in ox-LDL-stimulated VSMCs.
Decreased p62, PDK1, phosphorylated Akt, and phosphorylated mTOR levels in ox-LDL-stimulated VSMCs, indicating promotion of autophagy via suppression of the PDK1/Akt/mTOR pathway.
Co-treatment with chloroquine reversed BDMC's effects on lipid droplet area, total cholesterol content, triglyceride level, and cholesterol efflux in ox-LDL-stimulated VSMCs, confirming autophagy mediates BDMC's lipid-lowering action.
In Vivo
Bisdemethoxycurcumin (100 mg/kg; i.g.; daily; 3 days) alleviates LPS-induced acute lung injury in C57BL/6 mice by activating AMPKα, reducing lung injury, inflammation, and oxidative stress[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:apoe−/− (male, 8 weeks of age, fed high-fat diet for 7 weeks to induce atherosclerotic lesions)[3]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg
-
Administration:p.o.; daily; 4 weeks
-
Result:Significantly reduced the aortic lumen ratio (plaque diameter/intima thickness) compared to the HFD control.
Reduced serum low-density lipoprotein-cholesterol (LDL-c), total cholesterol, and triglyceride levels, and increased serum high-density lipoprotein-cholesterol (HDL-c) levels (20 mg/kg and 40 mg/kg doses, effects comparable to atorvastatin).
Significantly reduced serum levels of the inflammatory cytokines IL-1β, IL-6, and TNF-α.
Increased protein levels of Beclin-1, ABCA1, and the LC3B-II/LC3B-I ratio in aortic tissue compared to the HFD control.
Decreased protein levels of p62, PDK1, phosphorylated mTOR, and phosphorylated AKT in aortic tissue compared to the HFD control.
-
Animal Model:C57BL/6 (8-10-week-old; LPS-induced acute lung injury)[4]
-
Dosage:100 mg/kg
-
Administration:i.g.; daily; 3 days
-
Result:Significantly reduced LPS-induced lung inflammation score, apoptotic index, LDH activity in lung tissue, lung wet-to-dry ratio, and total protein concentration in BALF.
Decreased airway resistance, increased pulmonary ventilation, and normalized arterial blood gas parameters (PaO2, PaCO2, HCO3-) in LPS-treated mice.
Suppressed LPS-induced increases in lung and BALF levels of inflammatory cytokines IL-1β, IL-6, and TNF-α, reduced BALF infiltrations of total cells, macrophages, and neutrophils, and inhibited lung MPO activity.
Blocked LPS-elicited phosphorylation and nuclear translocation of NF-κB p65.
Decreased LPS-induced ROS generation and MDA levels in lung tissue, preserved GSH levels, total SOD activity, and SOD2 protein levels, and elevated NRF2 protein levels and transcriptional activity.
Had all protective effects almost completely blunted by AMPKα inhibition with Compound C.
Chemical Information
-
CAS No. 52328-96-8
-
Appearance Solid
-
Molecular Weight 308.33
-
Formula C19H16O4
-
Color White to off-white
-
SMILES
O=C(/C=C(O)/C=C/C1=CC=C(O)C=C1)/C=C/C2=CC=C(O)C=C2
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
ECM-Embedded Organoid (Matrigel/Dome) Culture
ECM-embedded organoid dome culture embeds epithelial stem cells, crypts, organoid fragments, or tumor-derived epithelial cells in a basement-membrane-like hydrogel such as Matrigel, allowing 3D growth, self-organization, lumen formation, budding or cystic morphogenesis, and lineage maintenance under defined niche-factor-containing medium. The primary readouts are organoid establishment efficiency, growth, morphology, passaging capacity, lineage-marker expression, and, when fluorescently labeled lines are used, microscopy- or flow-cytometry-based quantification of population behavior in 3D culture.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Matrigel Transwell/Boyden Chamber Invasion Assay
Matrigel Transwell/Boyden chamber invasion assay measures the ability of cells to degrade or traverse an extracellular matrix-coated porous membrane and move from an upper chamber toward a chemoattractant in a lower chamber. Invasion is distinguished from migration by coating the membrane with Matrigel or basement membrane matrix; uncoated inserts measure migration, while coated inserts require cells to cross an ECM barrier before reaching the underside of the membrane.
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Invadopodia/Fluorescent Gelatin Degradation Assay
Invadopodia/fluorescent gelatin degradation assay detects proteolytic extracellular matrix degradation by cancer-cell invadopodia, which are actin-rich protrusive structures associated with matrix remodeling, invasion, and metastasis. The readout is generated by culturing cells on fluorescent gelatin and measuring dark degraded areas where fluorescent substrate has been locally removed, often together with immunofluorescent detection of invadopodia markers such as F-actin, cortactin, and TKS5.
-
LPS-Induced Endotoxemia/Systemic Inflammation
Lipopolysaccharide (LPS)-induced endotoxemia is a widely used in vivo model of acute systemic inflammation in which LPS, a Gram-negative bacterial endotoxin, activates innate immune signaling primarily through TLR4, leading to rapid and transient induction of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in circulation and tissues. This cytokine surge is commonly used as a measurable readout of systemic inflammatory activation and immune dysregulation, and is typically assessed within hours after intraperitoneal LPS administration in mouse models of endotoxemia. The model captures key features of systemic inflammatory response syndrome, including cytokine release, immune cell activation, and downstream tissue responses, and has been used to evaluate anti-inflammatory interventions such as cytokine modulation, lipid mediators, and immune cell-targeting therapies.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Matrigel/ECM Transwell Invasion Assay
The Matrigel/ECM Transwell invasion assay measures the ability of cells to move toward a chemoattractant while crossing an extracellular-matrix barrier placed on a porous membrane; therefore, the readout reflects both chemotactic motility and matrix invasion rather than migration alone. Matrigel is a basement-membrane-rich matrix derived from Engelbreth-Holm-Swarm mouse sarcoma and has been used as a reconstituted basement membrane barrier in chemoinvasion assays. The assay readout is generated by quantifying cells that reach the underside of the insert membrane or lower compartment after incubation, commonly by staining and counting invaded cells or by fluorescence-based quantification.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
[3]. Zuo J, et al. Bisdemethoxycurcumin suppresses the progression of atherosclerosis and VSMC-derived foam cell formation by promoting lipophagy. Naunyn-Schmiedeberg's archives of pharmacology. 2023 Dec;396(12):3659-3670. [Content Brief]
[4]. Li H, et al. Bisdemethoxycurcumin alleviates LPS-induced acute lung injury via activating AMPKα pathway. BMC pharmacology & toxicology. 2023 Nov 20;24(1):63. [Content Brief]
[6]. Damrongrungruang T, et al. Combined bisdemethoxycurcumin and potassium iodide-mediated antimicrobial photodynamic therapy. Heliyon. 2023 Jul;9(7):e17490. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Bisdemethoxycurcumin
- 52328-96-8
- PI3K
- Akt
- p38 MAPK
- PDK-1
- mTOR
- Autophagy
- AMPK
- Keap1-Nrf2
- Interleukin Related
- TNF Receptor
- NOD-like Receptor (NLR)
- Pyroptosis
- Bacterial
- apoe?/? mice
- ATDC5 chondrocytes
- primary mouse peritoneal macrophages
- AKT1
- PIK3R1
- Candida albicans
- SRC
- RAW264.7 cells
- C57BL/6 mice
- EGFR
- Inhibitor
- inhibitor
- inhibit